Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform!
We are thrilled to announce the publication of our paper, ” An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers,” in the prestigious Advanced Science journal. Led by Dr. Hsing-Mao Chu, CEO of T-E Meds, this research brings us to achieve new breakthroughs in ADC technology and clinical medical applications.
Link to article: